BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32792423)

  • 1. Cohort profile: the Oxford Parkinson's Disease Centre Discovery Cohort MRI substudy (OPDC-MRI).
    Griffanti L; Klein JC; Szewczyk-Krolikowski K; Menke RAL; Rolinski M; Barber TR; Lawton M; Evetts SG; Begeti F; Crabbe M; Rumbold J; Wade-Martins R; Hu MT; Mackay C
    BMJ Open; 2020 Aug; 10(8):e034110. PubMed ID: 32792423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
    Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
    Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease.
    García-Lorenzo D; Longo-Dos Santos C; Ewenczyk C; Leu-Semenescu S; Gallea C; Quattrocchi G; Pita Lobo P; Poupon C; Benali H; Arnulf I; Vidailhet M; Lehericy S
    Brain; 2013 Jul; 136(Pt 7):2120-9. PubMed ID: 23801736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
    Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
    Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain atrophy in Parkinson's disease with polysomnography-confirmed REM sleep behavior disorder.
    Rahayel S; Gaubert M; Postuma RB; Montplaisir J; Carrier J; Monchi O; Rémillard-Pelchat D; Bourgouin PA; Panisset M; Chouinard S; Joubert S; Gagnon JF
    Sleep; 2019 Jun; 42(6):. PubMed ID: 30854555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased free water in the substantia nigra in idiopathic REM sleep behaviour disorder.
    Zhou L; Li G; Zhang Y; Zhang M; Chen Z; Zhang L; Wang X; Zhang M; Ye G; Li Y; Chen S; Li B; Wei H; Liu J
    Brain; 2021 Jun; 144(5):1488-1497. PubMed ID: 33880500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder.
    Sun J; Lai Z; Ma J; Gao L; Chen M; Chen J; Fang J; Fan Y; Bao Y; Zhang D; Chan P; Yang Q; Ye C; Wu T; Ma T
    Mov Disord; 2020 Mar; 35(3):478-485. PubMed ID: 31846123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal baseline brain activity in Parkinson's disease with and without REM sleep behavior disorder: A resting-state functional MRI study.
    Li D; Huang P; Zang Y; Lou Y; Cen Z; Gu Q; Xuan M; Xie F; Ouyang Z; Wang B; Zhang M; Luo W
    J Magn Reson Imaging; 2017 Sep; 46(3):697-703. PubMed ID: 27880010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent patterns of structural brain changes in rapid eye movement sleep behavior disorder and Parkinson's disease on behalf of the German rapid eye movement sleep behavior disorder study group.
    Holtbernd F; Romanzetti S; Oertel WH; Knake S; Sittig E; Heidbreder A; Maier A; Krahe J; Wojtala J; Dogan I; Schulz JB; Schiefer J; Janzen A; Reetz K
    Sleep; 2021 Mar; 44(3):. PubMed ID: 32974664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder.
    Ansari M; Rahmani F; Dolatshahi M; Pooyan A; Aarabi MH
    Sleep Breath; 2017 Mar; 21(1):155-161. PubMed ID: 27853964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Neuroimaging of Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease: A Systematic Review.
    Matzaras R; Shi K; Artemiadis A; Zis P; Hadjigeorgiou G; Rominger A; Bassetti CLA; Bargiotas P
    J Parkinsons Dis; 2022; 12(1):69-83. PubMed ID: 34806615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson's Disease.
    Boucetta S; Salimi A; Dadar M; Jones BE; Collins DL; Dang-Vu TT
    Sci Rep; 2016 Jun; 6():26782. PubMed ID: 27245317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.